Idamycin Pfs Solution
Product Images NDC 0013-2576

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Idamycin Pfs (NDC 0013-2576). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Idamycin 01)

FDA Label Image

Logo (Idamycin 02)

This text is a label of a medicine named "eP zer", manufactured by Pfizer Inc., and distributed to a hospital in New York, NY 10017.*

FDA Label Image

Principal Display Panel (5 mg/5 mL Vial Label)

This is a drug called Idamycin PFS, with the active ingredient idarubicin hydrochloride, in an injection format of 5mg/5mL. The drug is only for V, scanc, and Sodon use and should be stored under specific conditions to prevent damage. The drug may cause severe vesation and st necstcan and can be dangerous if extravasted. The package contains preservatives and should be discarded after use. There is dosage information available for this drug. The manufacturer is located in Australia and the drug is distributed by Phamasi & U. The package has a lot number and expiration date.*

FDA Label Image

Principal Display Panel (5 mg/5 mL Vial Carton)

Store under refrigeration 210 5°C (36" 10 46%9). Protect from light. Retain in-carrier until time of use. And water for injection, USP q.5.HCl s 20 Tt pH et S, st Soksion Starl, sl Sonic disused by Pharmacia & Uppin Co. Discard unused portion. The text contains some vague instructions for storing and using medications, but the specific medication or purpose is not clear.*

FDA Label Image

Principal Display Panel (10 mg/10 mL Vial Label)

This is a description for a medication with the NDC code 0013-2586-91. It is recommended to store the medication refrigerated at 2 to 8 degrees Celsius and protected from light. The medication is called Epirubicin and contains idarubicin hydrochloride. Its presentation includes a 10mg/10mL injection for intravenous use only. Additional prescribing information can be found in the accompanying documents. The medication is manufactured in Australia.*

FDA Label Image

Principal Display Panel (10 mg/10 mL Vial Carton)

FDA Label Image

Principal Display Panel (20 mg/20 mL Vial Label)

This is a medication labeled as NDC 0013-2596-91, with prescription information that contains darubicin hydrochloride for IV use only. The medication is stored in a 20mL single-dose container and is to be refrigerated at a temperature between 2° and 8°C until the time of use. The container should be protected from light, and any unused portion should be discarded. The text also contains a warning about severe celuits, vesication, and tissue necrosis that may occur if the medication is extravasated during administration. The prescribing information should be consulted for more details about dosage and use. There is no non-English character in the text.*

FDA Label Image

Principal Display Panel (20 mg/20 mL Vial Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.